NYSEARCA:BTAL

AGFIQ US MARKET NEUTRAL ANTI-BETA FUND Stock Forecast, Price & News

$16.94

-0.18 (-1.05%)

(As of 12/8/2021 12:00 AM ET)

Add

Today's Range: $16.88
▼
$17.10
50-Day Range: $16.20
▼
$17.51
52-Week Range: $16.15
▼
$19.58

Volume: 18,255 shs
Average Volume: 65,154 shs
Market Capitalization: $99.95 million

P/E Ratio: N/A
Dividend Yield: 0.00%
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive BTAL News and Ratings via Email

Sign-up to receive the latest news and ratings for AGFIQ US MARKET NEUTRAL ANTI-BETA FUND and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer AGFiQ

Fund NameAGFIQ US MARKET NEUTRAL ANTI-BETA FUND

Tax ClassificationRegulated Investment Company

SymbolNYSEARCA:BTAL

Inception Date9/12/2011

Fund ManagerWilliam DeRoche, Philip Lee

WebN/A

PhoneN/A

Fund Focus

Asset ClassEquity

BenchmarkDow Jones U.S. Thematic Market Neutral Anti-Beta Total Return Index

CategoryStrategy

FocusLong/Short

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$100.62 million

Average Daily Volume$50.51 thousand

Discount/Premium0.07%

ETF Expenses

Management Fee0.45%

Other Expenses2.56%

Total Expenses3.01%

Fee Waiver-0.48%

Net Expenses2.53%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.

AdvisorFFCM LLC

CustodianJPMorgan Chase Bank, N.A.

DistributorForeside Fund Services, LLC

Transfer AgentJPMorgan Chase Bank, N.A.

Trustee

Lead Market Maker

Geographic Exposure of BTAL

Currency Exposure of BTAL

Sector Exposure of BTAL

Industry Exposure of BTAL

AGFIQ US MARKET NEUTRAL ANTI-BETA FUND (NYSEARCA:BTAL) Frequently Asked Questions

How has AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock been impacted by Coronavirus?: AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock was trading at $26.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BTAL stock has decreased by 35.0% and is now trading at $16.94.
View which stocks have been most impacted by COVID-19.
What other stocks do shareholders of AGFIQ US MARKET NEUTRAL ANTI-BETA FUND own?: Based on aggregate information from My MarketBeat watchlists, some companies that other AGFIQ US MARKET NEUTRAL ANTI-BETA FUND investors own include Ajinomoto (AJINY), Advanced Energy Industries (AEIS), Autodesk (ADSK), Koninklijke Ahold Delhaize (ADRNY), Accenture (ACN), American Campus Communities (ACC), Abbott Laboratories (ABT), AbbVie (ABBV), Axon Enterprise (AAXN) and AAON (AAON).
What is AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock symbol?: AGFIQ US MARKET NEUTRAL ANTI-BETA FUND trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BTAL."
Who are AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's major shareholders?: AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock is owned by a number of retail and institutional investors. Top institutional investors include IFP Advisors Inc (0.42%) and AGF Investments LLC (0.07%).
Which major investors are buying AGFIQ US MARKET NEUTRAL ANTI-BETA FUND stock?: BTAL stock was purchased by a variety of institutional investors in the last quarter, including IFP Advisors Inc, and AGF Investments LLC.
How do I buy shares of AGFIQ US MARKET NEUTRAL ANTI-BETA FUND?: Shares of BTAL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is AGFIQ US MARKET NEUTRAL ANTI-BETA FUND's stock price today?: One share of BTAL stock can currently be purchased for approximately $16.94.
How much money does AGFIQ US MARKET NEUTRAL ANTI-BETA FUND make?: AGFIQ US MARKET NEUTRAL ANTI-BETA FUND has a market capitalization of $99.95 million.

This page was last updated on 12/9/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources